Estimates Revisions NovoCure Limited
Stocks
NVCR
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.31 USD | -4.23% |
|
+1.94% | +26.14% |
| 07-24 | Wedbush Adjusts Price Target on NovoCure to $20 From $18, Maintains Neutral Rating | MT |
| 07-23 | NovoCure Limited, Q2 2026 Earnings Call, Jul 23, 2026 |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| - | - | ||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Cash or Net Debt
- Stock Market
- Stocks
- NVCR Stock
- Consensus NovoCure Limited
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
